ML19032A513: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 15: | Line 15: | ||
=Text= | =Text= | ||
{{#Wiki_filter:Code of Federal Regulations}} | {{#Wiki_filter:Advisory Committee on the Medical Uses of Isotopes TELECONFERENCE AGENDA Tuesday, February 26, 2019 10:00 AM - 12:00 PM (ET) | ||
OPEN SESSION 10:00 am - 12:00 pm Discuss the ACMUI Training and Experience (T&E) Draft Subcommittee Report regarding the requirements for authorized users under Title 10 Code of Federal Regulations (10 CFR) 35.300, Use of unsealed byproduct material for which a written directive is required.}} | |||
Latest revision as of 01:55, 20 October 2019
| ML19032A513 | |
| Person / Time | |
|---|---|
| Issue date: | 02/01/2019 |
| From: | Advisory Committee on the Medical Uses of Isotopes |
| To: | |
| Jamerson, Kellee | |
| References | |
| Download: ML19032A513 (1) | |
Text
Advisory Committee on the Medical Uses of Isotopes TELECONFERENCE AGENDA Tuesday, February 26, 2019 10:00 AM - 12:00 PM (ET)
OPEN SESSION 10:00 am - 12:00 pm Discuss the ACMUI Training and Experience (T&E) Draft Subcommittee Report regarding the requirements for authorized users under Title 10 Code of Federal Regulations (10 CFR) 35.300, Use of unsealed byproduct material for which a written directive is required.